Experimental & Molecular Medicine · 2004 · 38 citations · 8 references
Life SciencesBiochemistryPharmacologyCellular BiochemistryEnzymologyMolecular PharmacologyEnzyme InhibitionMonoamine NeurochemistryCysteamine TherapyReducing ConditionsRepeat Expansion Disorders
The treatment of cystamine, a transglutaminase(TGase) inhibitor, has beneficial effects in several diseases including CAG-expansion disorders and cataract. We compared the inhibition characteristics of cystamine with those of cysteamine, a reduced form of cystamine expect-ed to be present inside cells. Cystamine is a more potent inhibitor for TGase than cysteamine with different kinetics pattern in a non-reducing condition. By contrast, under reducing conditions, the inhibitory effect of cystamine was comparable with that of cysteamine. How-ever, cystamine inhibited intracellular TGase activity more strongly than cysteamine despite of cytoplasmic reducing environment, suggest-ing that cystamine itself inhibits in situ TGase activity by forming mixed disulfides.
8
Therapeutic Effects of Cystamine in a Murine Model of Huntington's Disease
Alpaslan Dedeoglu, James K. Kubilus, Thomas M. Jeitner et al. · Journal of Neuroscience · 2002 · 315 citations · Full text
Cystamine Inhibits Caspase Activity
Mathieu Lesort, Matthew Lee, Janusz Tucholski et al. · Journal of Biological Chemistry · 2003 · 173 citations · Full text
Specificity of guinea pig liver transglutaminase for amine substrates
L. Lóránd, K. N. Parameswaran, P. Stenberg et al. · Biochemistry · 1979 · 119 citations